Literature DB >> 21769239

Alopecia areata - probing the deforestation.

Dilip Gude1.   

Abstract

Entities:  

Year:  2011        PMID: 21769239      PMCID: PMC3129127          DOI: 10.4103/0974-7753.82132

Source DB:  PubMed          Journal:  Int J Trichology        ISSN: 0974-7753


× No keyword cloud information.
Sir, Alopecia areata (AA) is a chronic inflammatory auto-immune disorder resulting in nonscarring hair loss. It is thought to be triggered by a collapse of immune privilege in hair follicles. The dominant role of Th1 cells is explained by the demonstration of infiltrating chemokine (C-C motif) receptor 5 (CCR5+) CD4+ T lymphocytes around hair follicles. Intralesional injections of both IL-4 and neutralizing anti-IFN-γ antibody have shown to suppress CD8+ T cell infiltrates around the hair follicles and repressed enhanced IFN-γ mRNA expression in the affected alopecic skin. Also Th1 transcription factor T-box21 (T-bet) small interfering RNAs (siRNA) mitigated alopecia and resulted in the restoration of hair shaft elongation.[1] Peripheral blood gene expression profiling of AA showed upregulation in immune response, cytokine signaling, signal transduction, cell cycle, proteolysis and cell adhesion-related genes. It also revealed the activation of several genes related to natural killer-cell cytotoxicity, apoptosis, mitogen activated protein kinase, Wnt signaling, and B- and T-cell receptor signaling in AA. A study showed that 363 genes (97 upregulated and 266 downregulated) were found to be differentially expressed in AA skin compared to nonlesional skin acting via T-cell mediated (CCL5, CXCL10, CD27, ICAM2, ICAM3, IL7R, and CX3CL1) and humoral mechanisms (IGHG3, IGHM, and CXCR5).[2] In an experimental model natural killer (NK) cell depletion (tested by injecting anti-asialo GM1 antibodies) significantly increased perifollicular CD49b+T cells in the alopecic skin. The study shows evidence that IFN-c secreting CD49b+ T-cell subsets, by evoking strong Th1 response (cytokines IL-2, IL-12,interferon-γ and IL-1RA), are inappropriately stimulated by the receptor-activating signals released from the hair follicle epithelium and⁄or are inadequately suppressed in AA and that some NK cells are actually protective at least early on.[3] Genetic variants in the FAS and FASLG genes (FasL or CD95L; a type-II transmembrane protein of TNF family),[4] an immune response to trichohyalin and Keratin-K16, reduced expression of red/IK cytokine (antagonist of IFNγ-induced expression of MHC class II antigens and a regulator of CD34+ cell growth) and indoleamine 2,3-dioxygenase have all been incriminated in the pathogenesis of AA. That AA shares etiology with other autoimmune disorders is suggested by establishing the involvement of the TRAF1/C5 (TNF receptor-associated factor 1, complement component 5) locus in the causation of familial and severe AA.[5] The characteristic yellow dot pattern seen in reflectance confocal microscopy with round or polycyclic yellow-pink dots with miniaturized or broken hair shafts corresponds to the chronic phase of AA (depicting dilated infundibula of the vellus like anagen and telogen follicles). Increased serum sIL-2R level and lower IL-18 level at baseline are poor prognostic markers in AA. Coudability hairs (normal-looking hairs tapered at the proximal end) are useful in gauging the disease activity in AA and may surrogate the hair-pull test. A variety of treatment options such as phototoxic psoralen and ultraviolet-A therapy after topical application of 0.1% 8-methoxypsoralen, diphencyprone, dinitrochlorobenzene, squaric acid dibutylester, steroids, minoxidil, anthralin, and bexarotene have shown promise in managing AA.
  5 in total

1.  Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures.

Authors:  Raghunandan Dudda Subramanya; Alvin B Coda; Animesh A Sinha
Journal:  Genomics       Date:  2010-05-28       Impact factor: 5.736

2.  Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis.

Authors:  X Fan; L Shangguan; M Li; C Y Li; B Liu
Journal:  Br J Dermatol       Date:  2010-04-15       Impact factor: 9.302

3.  An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?

Authors:  Gil Kaufman; Roberto d'Ovidio; Anis Kaldawy; Bedia Assy; Yehuda Ullmann; Amos Etzioni; Ralf Paus; Amos Gilhar
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

4.  Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model.

Authors:  Motonobu Nakamura; Jun-ichiro Jo; Yasuhiko Tabata; Osamu Ishikawa
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

5.  The TRAF1/C5 locus confers risk for familial and severe alopecia areata.

Authors:  S Redler; F F Brockschmidt; L Forstbauer; K A Giehl; C Herold; S Eigelshoven; S Hanneken; J De Weert; G Lutz; H Wolff; R Kruse; B Blaumeiser; M Böhm; T Becker; M M Nöthen; R C Betz
Journal:  Br J Dermatol       Date:  2009-12-17       Impact factor: 9.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.